Page last updated: 2024-10-31

mirtazapine and Hepatitis C

mirtazapine has been researched along with Hepatitis C in 2 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aung, AK1
Robinson, J1
Hey, P1
Lehmann, M1
Chow, Y1
Stark, RJ1
Bosco, JJ1
Nickel, T1
Sonntag, A1
Backmund, M1
Pollmächer, T1

Other Studies

2 other studies available for mirtazapine and Hepatitis C

ArticleYear
Progressive multifocal leukoencephalopathy secondary to hepatitis C virus infection-related T-cell lymphopenia.
    Internal medicine journal, 2019, Volume: 49, Issue:1

    Topics: Aged; Antiviral Agents; Brain; Fatal Outcome; Hepatitis C; Humans; JC Virus; Leukoencephalopathy, Pr

2019
Depression during therapy with interferon alpha--how long should an antidepressant treatment last?
    Pharmacopsychiatry, 2005, Volume: 38, Issue:2

    Topics: Antidepressive Agents, Tricyclic; Antiviral Agents; Depressive Disorder; Hepatitis C; Humans; Interf

2005